South Korea · Delayed Price · Currency is KRW GeneOne Life Science Statistics
Total Valuation
KRX:011000 has a market cap or net worth of KRW 48.42 billion. The enterprise value is 76.85 billion.
| Market Cap | 48.42B |
| Enterprise Value | 76.85B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:011000 has 18.13 million shares outstanding. The number of shares has decreased by -61.22% in one year.
| Current Share Class | 18.13M |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | -61.22% |
| Shares Change (QoQ) | +4.46% |
| Owned by Insiders (%) | 6.78% |
| Owned by Institutions (%) | 7.91% |
| Float | 16.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.92 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38, with a Debt / Equity ratio of 0.98.
| Current Ratio | 0.38 |
| Quick Ratio | 0.14 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.64 |
| Interest Coverage | -7.85 |
Financial Efficiency
Return on equity (ROE) is -99.68% and return on invested capital (ROIC) is -32.99%.
| Return on Equity (ROE) | -99.68% |
| Return on Assets (ROA) | -20.90% |
| Return on Invested Capital (ROIC) | -32.99% |
| Return on Capital Employed (ROCE) | -66.85% |
| Weighted Average Cost of Capital (WACC) | 9.82% |
| Revenue Per Employee | 301.59M |
| Profits Per Employee | -1.19B |
| Employee Count | 41 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 2.13 |
Taxes
| Income Tax | -108.82M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.42% in the last 52 weeks. The beta is 0.72, so KRX:011000's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -79.42% |
| 50-Day Moving Average | 4,971.70 |
| 200-Day Moving Average | 8,185.68 |
| Relative Strength Index (RSI) | 27.54 |
| Average Volume (20 Days) | 812,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:011000 had revenue of KRW 12.37 billion and -48.94 billion in losses. Loss per share was -2,698.70.
| Revenue | 12.37B |
| Gross Profit | -16.92B |
| Operating Income | -41.99B |
| Pretax Income | -49.04B |
| Net Income | -48.94B |
| EBITDA | -24.87B |
| EBIT | -41.99B |
| Loss Per Share | -2,698.70 |
Balance Sheet
The company has 5.87 billion in cash and 35.05 billion in debt, with a net cash position of -29.18 billion or -1,608.88 per share.
| Cash & Cash Equivalents | 5.87B |
| Total Debt | 35.05B |
| Net Cash | -29.18B |
| Net Cash Per Share | -1,608.88 |
| Equity (Book Value) | 35.69B |
| Book Value Per Share | 1,968.19 |
| Working Capital | -38.04B |
Cash Flow
In the last 12 months, operating cash flow was -13.27 billion and capital expenditures -18.62 million, giving a free cash flow of -13.29 billion.
| Operating Cash Flow | -13.27B |
| Capital Expenditures | -18.62M |
| Depreciation & Amortization | 17.12B |
| Net Borrowing | 5.35B |
| Free Cash Flow | -13.29B |
| FCF Per Share | -732.99 |
Margins
| Gross Margin | -136.84% |
| Operating Margin | -339.57% |
| Pretax Margin | -396.63% |
| Profit Margin | n/a |
| EBITDA Margin | -201.15% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KRX:011000 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 61.22% |
| Shareholder Yield | 61.22% |
| Earnings Yield | -101.07% |
| FCF Yield | -27.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 3, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KRX:011000 has an Altman Z-Score of -3.35 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.35 |
| Piotroski F-Score | 1 |